ST
$29.81
-0.18
(-0.60%)
As of Sep 5, 2026, 11:00 AM EDT
Price history
Stoke Therapeutics Inc (STOK) is trading down at $29.81 (-0.60%), as of the latest quote. It is a Russell 2000 constituent in the Health Care sector.
IPO: June 19, 2019 · $18.00 offering · NASDAQ · View IPO details →
Recent News (2)
-
Stoke Therapeutics and Biogen Present Long-Term Clinical Data that Support the Disease-Modifying Potential of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) –4-year data from the Phase 1/2a open-label extension (OLE) studies showed substantial and durable reductions in seizures and continuing improvements in cognition and behavior in patients treated with…
-
Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16th European Epilepsy Congress (EEC) –4-year data from the Phase 1/2a open-label extension (OLE) studies support the potential disease-modifying effects of zorevunersen–
More Health Care stocks
- AZN AstraZeneca
- ILMN Illumina
- A Agilent Technologies
- ABBV AbbVie
- ABT Abbott Laboratories
- ALGN Align Technology
- AMGN Amgen
- BAX Baxter International